Shoulder Innovations, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NYSE
Shoulder Innovations, a commercial-stage medical technology company focused on shoulder surgical care, is pursuing an initial public offering of 5 million shares to fund its rapid growth, despite reporting increasing net losses and significant operating expenses.
NYSE
Shoulder Innovations, a medical technology company focused on shoulder surgical care, filed an S-1/A for its initial public offering, showcasing significant revenue growth but also increasing net losses and detailing a recent $40 million convertible note financing.
NYSE
Shoulder Innovations, a commercial-stage medical technology company focused on shoulder surgical care, filed an S-1/A amendment for its initial public offering, revealing significant revenue growth, continued net losses, and plans to list on the NYSE under the symbol 'SI'.
NYSE
Shoulder Innovations, a commercial-stage medical technology company focused on shoulder surgical care, has filed an S-1 registration statement for an initial public offering, showcasing significant revenue growth and strategic plans for market expansion and product innovation.